NCT05044104 is a NA clinical trial of Consumer-facing wearable smart watch in Healthy, sponsored by Mayo Clinic.

Who is sponsoring NCT05044104?

NCT05044104 is sponsored by Mayo Clinic.

What drugs are being tested in NCT05044104?

Interventions in NCT05044104: Consumer-facing wearable smart watch.

Is NCT05044104 still recruiting?

NCT05044104 is currently completed. Last updated 20 July 2023.

Are results published for NCT05044104?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2023-07-20 · How we verify

NCT05044104

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Wearable Technology in Endoscopy

Completed NA Results posted Last updated 20 July 2023

What this trial tests

NA trial testing Consumer-facing wearable smart watch in Healthy in 292 participants. Completed in 1 September 2022.

Timeline

11 January 2022

Primary endpoint
1 September 2022

1 September 2022

Quick facts

Lead sponsor	Mayo Clinic
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	292
Start date	11 January 2022
Primary completion	1 September 2022
Estimated completion	1 September 2022
Sites	1 location across United States

Drugs / interventions tested

Consumer-facing wearable smart watch

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Recorded Tachycardia Events Primary · Anesthesia Duration, approximately 30 to 45 minutes

Number of tachycardia events recorded as defined as heart rate \> 100 bpm

Anesthesia Monitoring

Group	Value	95% CI
Patients Undergoing Gastrointestinal Endoscopy With Sedation	9

Smartwatch

Group	Value	95% CI
Patients Undergoing Gastrointestinal Endoscopy With Sedation	3

Smartwatch Accessories

Group	Value	95% CI
Patients Undergoing Gastrointestinal Endoscopy With Sedation	22

Recorded Bradycardia Events Primary · Anesthesia Duration, approximately 30 to 45 minutes

Number of bradycardia events recorded as defined as heart rate \< 60 bpm

Anesthesia Monitoring

Group	Value	95% CI
Patients Undergoing Gastrointestinal Endoscopy With Sedation	119

Smartwatch

Group	Value	95% CI
Patients Undergoing Gastrointestinal Endoscopy With Sedation	67

Accessories

Group	Value	95% CI
Patients Undergoing Gastrointestinal Endoscopy With Sedation	33

Recorded Desaturation Events Primary · Anesthesia Duration, approximately 30 to 45 minutes

Number of desaturation events recorded as defined as peripheral O2 saturation \<88%

Anesthesia Monitoring

Group	Value	95% CI
Patients Undergoing Gastrointestinal Endoscopy With Sedation	91

Smartwatch

Group	Value	95% CI
Patients Undergoing Gastrointestinal Endoscopy With Sedation	0

Smartwatch Accessories

Group	Value	95% CI
Patients Undergoing Gastrointestinal Endoscopy With Sedation	71

Recorded Arrhythmia Events Primary · Anesthesia Duration, approximately 30 to 45 minutes

Number of arrhythmia events recorded

Anesthesia Monitoring

Group	Value	95% CI
Patients Undergoing Gastrointestinal Endoscopy With Sedation	1

Smartwatch

Group	Value	95% CI
Patients Undergoing Gastrointestinal Endoscopy With Sedation	0

Smartwatch accessories

Group	Value	95% CI
Patients Undergoing Gastrointestinal Endoscopy With Sedation	0

Recorded Tachypnea Primary · Anesthesia Duration, approximately 30 to 45 minutes

Number of tachypnea events recorded as defined as respiratory rate \>18 breaths per minute

Anesthesia Monitoring

Group	Value	95% CI
Patients Undergoing Gastrointestinal Endoscopy With Sedation	29

Smartwatch

Group	Value	95% CI
Patients Undergoing Gastrointestinal Endoscopy With Sedation	0

Smartwatch accessories

Group	Value	95% CI
Patients Undergoing Gastrointestinal Endoscopy With Sedation	0

Sponsor's own description

Researchers are assessing the accuracy and safety of wearable technology in subjects undergoing endoscopic gastrointestinal procedures with sedation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other Mayo Clinic trials

Trials by the same sponsor.

NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05044104 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 20 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05044104.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing

NCT05044104

Quick facts

Drugs / interventions tested

Conditions studied

Sponsor

Who can join

Results — posted to ClinicalTrials.gov

Sponsor's own description

Publications & conference data

Related trials

Other recruiting trials for Healthy

Other Mayo Clinic trials

Verify against primary sources